Detalhe da pesquisa
1.
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
Oncologist
; 26(3): e414-e424, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33274542
2.
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW.
J Gastroenterol Hepatol
; 33(4): 814-824, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28960444
3.
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab.
Br J Cancer
; 115(8): 974-982, 2016 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27623234
4.
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.
Gastric Cancer
; 19(3): 927-38, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26510663
5.
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Lancet Oncol
; 15(11): 1224-35, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25240821
6.
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
Lancet
; 373(9674): 1525-31, 2009 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-19410716
7.
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data.
J Gastric Cancer
; 17(2): 132-144, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28680718
8.
Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia.
J Neuroimmunol
; 160(1-2): 92-101, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15710462
9.
Leukocytoclastic vasculitis and acute renal failure after influenza vaccination in an elderly patient with myelodysplastic syndrome.
Onkologie
; 29(10): 470-2, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17028456
10.
Loss of p53 impedes the antileukemic response to BCR-ABL inhibition.
Proc Natl Acad Sci U S A
; 103(19): 7444-9, 2006 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-16651519
11.
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
Blood
; 106(6): 2162-8, 2005 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15920007
12.
Adding weekly irinotecan to high-dose 5-fluorouracil and folinic acid (HD-5-FU/FA) after failure for first-line HD-5-FU/FA in advanced colorectal cancer--a phase II study.
Anticancer Drugs
; 13(10): 999-1004, 2002 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-12439333